MedPath

Abbott Laboratories Limited

🇨🇷Costa Rica
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Phase 4:1

Drug Approvals

13

NMPA:8
SFDA:5

Drug Approvals

Fenofibrate Capsules

Product Name
力平之
Approval Number
国药准字HJ20181239
Approval Date
Oct 14, 2022
NMPA

Fenofibrate Capsules

Product Name
力平之
Approval Number
国药准字HJ20181240
Approval Date
Oct 14, 2022
NMPA

Omega-3-acid ethyl ester 90 Soft Capsules

Product Name
ω-3脂肪酸乙酯90软胶囊
Approval Number
国药准字HJ20220042
Approval Date
Apr 29, 2022
NMPA

Choline Fenofibrate Sustained-release Capsules

Product Name
非诺贝特酸胆碱缓释胶囊
Approval Number
国药准字HJ20210070
Approval Date
Sep 7, 2021
NMPA

Pinaverium Bromide Tablets

Product Name
得舒特
Approval Number
国药准字HJ20160396
Approval Date
Mar 2, 2021
NMPA

Clarithromycin Tablets

Product Name
克拉仙
Approval Number
H20160082
Approval Date
Dec 16, 2019
NMPA

Clarithromycin Tablets

Product Name
克拉仙
Approval Number
H20160083
Approval Date
Dec 16, 2019
NMPA

Clarithromycin Tablets

Product Name
克拉霉素片
Approval Number
国药准字J20171070
Approval Date
Oct 24, 2017
NMPA

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 4
1 (100.0%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.